一次性注射器的全球市場-2022-2029

市場動態

全球一次性注射器市場的增長受到某些因素的推動，例如各種非政府組織為提高對一次性注射器的認識而開展的活動增加、遏制艾滋病毒等疾病傳播的需要以及對注射藥物的需求增加。拖曳。

預計在預測期內，不斷上升的交通事故將推動全球一次性注射器市場。

注射藥物的使用顯著增加，主要是由於傳統給藥方法的生物利用度不足。許多口服給藥的藥物在初始代謝過程中被降解，當它們到達體循環時使其失效。另一方面，注射劑直接分佈在全身，因此它們可以更快地發揮作用。此外，越來越多的針刺傷也增加了對安全注射器的需求。這些優勢也推動了注射器的日益普及，從而推動了全球一次性注射器市場的增長。此外，預計對疫苗的需求增加將促進注射器，特別是一次性注射器在世界發展中地區的銷售。

主要包括生物製劑的注射劑領域的持續增長是全球一次性注射器市場的主要推動力。超過 60% 的臨床開發藥物是生物製劑。這表明生物製劑市場的強勁增長。預計這將提振一次性注射器市場。對即時管理的需求不斷增長，一次性注射器製造技術的進步正在推動全球一次性注射器市場的發展。

突破性創新，例如引入兩步式一次性自動注射器，正在推動全球一次性注射器市場的增長。一次性注射器市場的公司正在加大力度推出適應各種藥物粘度的設備。改進設備設計以消除對定制系統組件的需求也越來越受到重視。一種新的兩級一次性自動注射器克服了與集成不良的系統相關的破損和不兼容的挑戰。

與一次性注射器相關的嚴格法規阻礙了一次性注射器市場的增長

一次性注射器在可用性和安全性方面存在若干限制，例如過敏反應、傷口擦傷和皮膚感染。它也被 FDA 歸類為 II 類，在印度根據藥品和化妝品法案 (1940) 歸類為 B 類，這構成了需要臨床試驗的稍高的風險，導致進一步的法律並發症。這些材料的安全性、質量和性能需要出於公共衛生目的進行嚴格評估，因此需要遵守複雜而嚴格的附屬機構規定。因此，這些因素正在阻礙一次性注射器市場的增長。

行業分析

全球一次性注射器市場根據波特五力分析、供應鏈分析、監管分析、定價分析和產品分析等各種行業因素對市場進行了深入分析。

全球一次性注射器市場報告提供了大約 40 多個市場數據表、45 多個數字和 180 頁的結構。

內容

第1章研究方法與範圍

• 調查方法
• 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

• 按產品劃分的市場細分
• 按應用劃分的市場細分
• 最終用戶的市場細分
• 按地區劃分的市場細分

第 4 章動力學

• 市場影響因素
• 驅動程序
  • 增加各種非政府組織的活動，以提高對使用一次性注射器的認識
  • 需要遏制艾滋病毒等疾病的傳播
  • 對注射藥物的需求不斷上升
• 限制因素
  • 一次性費用相對較高
• 嚴格的政府法規
• 商機

第5章行業分析

• 波特五力分析
• 供應鏈分析
• 監管分析
• 定價分析
• 產品分析
• 售後服務分析

第 6 章按產品分類

• 常規一次性注射器
• 安全的一次性注射器
• 針
• 口服注射器
• 填充針

第 7 章按應用程序

• 疫苗注射器
• 治療性注射

第 8 章最終用戶

• 醫院
• 診斷實驗室
• 血庫
• 製藥行業
• 疫苗接種
• 獸藥

第 9 章按地區

• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他歐洲地區
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 其他亞太地區
• 中東和非洲

第 10 章競爭格局

• 競爭場景
• 市場定位/市場份額分析
• 併購分析

第 11 章公司簡介

• 百特國際公司
  • 公司簡介
  • 產品組合和描述
  • 主要發展狀況
  • 財務摘要
• B. Braun Melsungen AG
• Becton
• Dickinson and Company
• Cardinal Health
• Henke-Sass Wolf
• Nipro Medical Corporation
• Novo Nordisk A/S
• Retractable Technologies, Inc.
• Vita Needle Company（*List is not exhaustive）

第12章 DataM

Market Overview

Disposable Syringes Market is estimated to reach at a CAGR of 6.5% during the forecast period (2022-2029).

Surgical glues (also called surgical sealants or adhesives) are used after a surgery or traumatic injury to bind together external or internal tissue. Surgical glues can be used in conjunction with or as an alternative to sutures and staples; they use a chemical bond to hold tissue together for healing or serve as a barrier to stop bodily fluids flow.

Advancements in the Disposable Syringes market were primarily aimed at addressing the limitations of traditional wound sealing techniques. Furthermore, due to surgical glue's favorable biological and physical properties, more surgeons are using this technique to seal wounds. Disposable Syringes is derived from several natural biopolymers, including gelatin, collagen, chitosan, albumin, and fibrin. A syringe designed for one-time use and is discarded after the use is called a disposable syringe. Furthermore, a syringe is defined as a sterile cylindrical medical instrument that has a thin hollow needle at the end. Besides, this device acts as a pump, which is used to draw therapeutic liquid formulations from vials and deliver them to a patient's bloodstream. However, within more modern times, the disposable syringe has risen in popularity over the traditional reusable syringe. The primary difference being that a disposable syringe is intended for one-time use and is then disposed of, typically into a contamination unit.

Market Dynamics

The global disposable syringes market growth driven by certain factors such by increasing number of activities by various NGOs that create awareness for disposable syringes, the need to control the spread of diseases like HIV, and the rising demand for injectable drugs.

Increasing incidences of road accidents, is expected to drive the global disposable syringes market during the forecast period

There has been a marked increase in the use of injectable drugs, primarily due to the lack of bioavailability in conventional drug delivery methods. Many orally administered drugs are subject to decomposition during the first-pass metabolism, which renders them ineffective by the time they reach the systemic circulation. On the other hand, injectable drugs directly enter the systemic circulation and provide the desired effect with a quicker onset of action. Furthermore, there are rising cases of needlestick injuries that are driving the demand for safety syringes. These advantages are also responsible for the increased adoption of injectable drugs and the global disposable syringes market's consequent growth. Furthermore, the increasing demand for vaccines is expected to drive syringes' sales, particularly disposable syringes, in the developing regions of the world.

The sustained growth of the injectable drugs sector, which primarily includes biologics, is the major factor driving the global disposable syringes market. More than 60% of drugs in clinical development are biologics. This indicates the strong growth of the biologics market. In turn, this is expected to boost the disposable syringes market. The rise in demand for point-of-care administration and technological advancements in the manufacturing of disposable syringes fuel the global disposable syringes market.

Ground breaking innovations such as introducing two-step disposable auto-injector devices are bolstering the growth of the global disposable syringes market. Companies in the market for disposable syringes are increasing efforts to introduce devices that cater to different drugs' viscosities. They are increasing focus to deliver design improvements in devices that eliminate the need for customizing system components. Novel two-step disposable autoinjector devices are overcoming challenges of breakage and incompatibility associated with poorly integrated systems.

Strict regulations associated with Disposable Syringes hampering the growth of the Disposable Syringes market

Disposable Syringes has several limitations associated with its usability and safety, such as allergic reactions, wound dehiscence, and skin infections. Besides, it is categorized as class II by the FDA and class B by the Drugs and Cosmetics Acts (1940) in India, making it a little risky and thus requiring clinical trials and further leading to legal complexities. The safety, quality, and performance of these materials are necessary facets requiring stringent evaluation for public health, which lead to complex and strict regulations for their affiliation. Therefore, these factors are hampering the growth of the Disposable Syringes market.

Industry Analysis

The global Disposable Syringes market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, product analysis etc.

Segment Analysis

The cyanoacrylates segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The cyanoacrylates segment held the largest market share. Cyanoacrylate is a sticky substance found in many types of glue. Cyanoacrylate poisoning occurs when someone swallows this substance or gets it on their skin. Once the applicator is initiated and the cyanoacrylate adhesive is applied to moist tissue, the polymerization process occurs. A feature of our cyanoacrylate devices is that only a low heat level is generated when this polymerization starts. Consequently, the patient does not experience the stinging or burning sensation that occurs with some competitor products.

Cyanoacrylate glue is biocompatible and does not need removal as it naturally slough off the skin as part of the natural wound healing process. Cyanoacrylate properties, namely fast-setting, high tensile strength polymers that bind with the skin's surface and are flexible, durable, waterproof, and transparent on the setting, make cyanoacrylate ideal for wound closure and skin barrier products. Cyanoacrylates provide a non-traumatic means of wound closure and enhance the patient experience over conventional wound closure methods. They are commonly used to close laparoscopic incisions and are much stronger than fibrin sealants and sutures. Cyanoacrylates are waterproof, flexible, and require no dressing on the wound.

Geographical Analysis

North America region holds the largest market share of the global Disposable Syringes market

North America region is dominating the global Disposable Syringes market accounted for the largest market share in 2021, owing to advanced healthcare infrastructure and experienced professionals in this region which leads to higher adoption of Disposable Syringes in hospitals, specialty clinics, and diagnostic centers. Also, growing awareness of the benefits of non-invasive medical aesthetic treatments is also boosting the growth of the market. The number of breast augmentation and liposuction procedures in the United States has always been high.

Canada's aesthetic device market is a highly diversified and export-oriented industry that manufactures equipment and supplies where purchasers include Canadian and international hospitals, physician's offices, laboratories, clinics, as well as patients (through direct purchases). The aesthetic device sector is populated with companies driven by product innovation. The industry is able to draw on world-class innovative research being conducted in Canadian universities, research institutes, and hospitals, some of which have been spun-off into Canadian medical device companies. Around 10% of Canada's medical device companies have spun off from Canadian research organizations.

Competitive Landscape

The global Disposable Syringes market is fragmented with the presence of a large number of market players. Some of the major players contributing to the growth of the Disposable Syringes market are Allergan Plc., Bausch Health Companies Inc., Cutera Palomar Medical Technologies, Cynosure Inc., Fosun International Ltd., Fotona Inc., Lutronic Inc., Sciton Inc., among others. Rising awareness toward aesthetic-based skin and body rejuvenation lasers and energy devices have increased the revenue opportunities for leading manufacturers to invest in the Disposable Syringes market.

The key players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Disposable Syringes market globally. For instance,

• In August 2020, the US-based Sensus Healthcare has acquired mobile aesthetic laser companies Aesthetic Mobile Laser Services and Aesthetic Laser Partners in Florida, US. The transactions are expected to bring in approximately $1m in revenues over the next 12 months.
• In May 2020, AbbVie has completed the acquisition of Allergan. AbbVie planning to launch Allergan Aesthetics, a global subsidiary under the umbrella of the AbbVie-Allergan merger.
• In November 2019, Baring Private Equity Asia announced that its affiliated private equity funds have agreed to acquire Lumenis, a leading provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT, and gynecology from XIO. The transaction values Lumenis at an enterprise value of over $1 billion.

Key Companies to Watch

Allergan Plc

Overview: Allergan Plc is a bold, global pharmaceutical company. It is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Product Portfolio: CoolTone Device- The CoolTone device is FDA-cleared for improvement of abdominal tone, strengthening of the abdominal muscles, and development for firmer abdomen. CoolTone is also FDA-cleared for strengthening, toning, and firming of buttocks and thighs.

The global Disposable Syringes market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Product
• 3.2. Market Snippet by Application
• 3.3. Market Snippet by End-User
• 3.4. Market Snippet by Region

4. Dynamics

• 4.1. Market Impacting Factors
• 4.2. Drivers
  • 4.2.1. Increasing Activities by Various NGO's that Create Awareness for the Use of Disposable Syringes
  • 4.2.2. Need to Control the Spread of Diseases like HIV
  • 4.2.3. Rising Demand for Injectable Drugs
• 4.3. Restraints
  • 4.3.1. Comparatively High One-time Cost
• 4.4. Stringent Government Regulations
• 4.5. Opportunity

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis
• 5.4. Pricing Analysis
• 5.5. Product Analysis
• 5.6. Post Sales Services Analysis

6. By Product

• 6.1. Introduction
  • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 6.1.2. Market Attractiveness Index, By Product
• 6.2. Conventional Disposable Syringes *
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
• 6.3. Safety Disposable Syringes
• 6.4. Needles
• 6.5. Oral Syringes
• 6.6. Filling Needles

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Immunization injections
• 7.3. Introduction
• 7.4. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
• 7.5. Therapeutic injections

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospitals
• 8.3. Introduction
• 8.4. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
• 8.5. Diagnostic Laboratories
• 8.6. Blood Banks
• 8.7. Pharmaceutical Industry
• 8.8. Vaccination
• 8.9. Veterinary Purposes

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.2.7.1. The U.S.
    • 9.2.7.2. Canada
    • 9.2.7.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. The U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. Australia
    • 9.5.6.5. Rest of Asia Pacific
• 9.6. The Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Baxter International Inc.*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Key Developments
  • 11.1.4. Financial Overview
• 11.2. B. Braun Melsungen AG
• 11.3. Becton
• 11.4. Dickinson and Company
• 11.5. Cardinal Health
• 11.6. Henke-Sass Wolf
• 11.7. Nipro Medical Corporation
• 11.8. Novo Nordisk A/S
• 11.9. Retractable Technologies, Inc.
• 11.10. Vita Needle Company (*List is not exhaustive)

12. DataM Intelligence

• 12.1. Appendix
• 12.2. About Us and Services
• 12.3. Contact Us